Mesoblast (MESO) Other Working Capital Changes (2016 - 2023)
Mesoblast (MESO) posted quarterly Other Working Capital Changes of -$682000.0 for Q1 2023, up 40.44% year-on-year from -$485628.1 in Q1 2022, and down 55.35% on a QoQ basis from -$439000.0 in Q4 2022.
Mesoblast (MESO) Other Working Capital Changes (2016 - 2023) Analysis & Trends
Mesoblast (MESO) has reported Other Working Capital Changes for 8 consecutive years, with -$682000.0 the latest figure, recorded in Q1 2023.
- Quarterly Other Working Capital Changes rose 40.44% year-over-year to -$682000.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was -$2.2 million (up 30.41% YoY) and the FY2022 annual result came in at -$2.8 million, up 4.88% from the prior year.
- Other Working Capital Changes retreated to -$682000.0 in Q1 2023 per MESO's latest filing, from -$439000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for MESO reached as high as $2.4 million in Q1 2022 and fell as low as -$3.3 million in Q4 2021.
- A 5-year average of $294750.0 and a median of $1.0 million in 2020 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2020 — Other Working Capital Changes plunged 1084.48% — and 2021, when it surged 86.77%.
- Year by year, Other Working Capital Changes stood at -$360000.0 in 2019, then slumped by 118.06% to -$785000.0 in 2020, then soared by 32.74% to -$528000.0 in 2021, then gained by 16.86% to -$439000.0 in 2022, then sank by 55.35% to -$682000.0 in 2023.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$682000.0, -$439000.0, and -$670000.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 1.25 Mn |
| Mar 31, 2023 | 1.25 Mn |
| Mar 31, 2023 | 1.25 Mn |
| Dec 31, 2022 | -1.77 Mn |
| Dec 31, 2022 | -1.77 Mn |
| Dec 31, 2022 | -1.77 Mn |
| Sep 30, 2022 | 1.34 Mn |
| Sep 30, 2022 | 1.34 Mn |
| Sep 30, 2022 | 1.34 Mn |
| Mar 31, 2022 | 2.39 Mn |
| Mar 31, 2022 | 2.39 Mn |
| Mar 31, 2022 | 2.39 Mn |
| Dec 31, 2021 | -3.33 Mn |
| Dec 31, 2021 | -3.33 Mn |
| Dec 31, 2021 | -3.33 Mn |
| Sep 30, 2021 | 1.84 Mn |
| Sep 30, 2021 | 1.84 Mn |
| Sep 30, 2021 | 1.84 Mn |
| Sep 30, 2020 | 795,000.00 |
| Sep 30, 2020 | 795,000.00 |